Crohn's disease and ulcerative colitis, the two common forms of inflammatory bowel disease (IBD), affect over 2.5 million people of European ancestry, with rising prevalence in other populations 1 . Genome-wide association studies and subsequent meta-analyses of these two diseases 2,3 as separate phenotypes have implicated previously unsuspected mechanisms, such as autophagy 4 , in their pathogenesis and showed that some IBD loci are shared with other inflammatory diseases 5 . Here we expand on the knowledge of relevant pathways by undertaking a meta-analysis of Crohn's disease and ulcerative colitis genome-wide association scans, followed by extensive validation of significant findings, with a combined total of more than 75,000 cases and controls. We identify 71 new associations, for a total of 163 IBD loci, that meet genome-wide significance thresholds. Most loci contribute to both phenotypes, and both directional (consistently favouring one allele over the course of human history) and balancing (favouring the retention of both alleles within populations) selection effects are evident. Many IBD loci are also implicated in other immune-mediated disorders, most notably with ankylosing spondylitis and psoriasis. We also observe considerable overlap between susceptibility loci for IBD and mycobacterial infection. Gene co-expression network analysis emphasizes this relationship, with pathways shared between host responses to mycobacteria and those predisposing to IBD.
We conducted an imputation-based association analysis using autosomal genotype-level data from 15 genome-wide association studies (GWAS) of Crohn's disease and/or ulcerative colitis (Supplementary Fig. 1 and Supplementary Table 1 ). We imputed 1.23 million singlenucleotide polymorphisms (SNPs) from the HapMap3 reference set (Supplementary Methods 1a), resulting in a high-quality data set with reduced genome-wide inflation ( Supplementary Figs 2 and 3 ) compared with previous meta-analyses of subsets of these data 2, 3 . The imputed GWAS data identified 25,075 SNPs that were associated (P , 0.01) with at least one of the Crohn's disease, ulcerative colitis, or combined IBD analyses. A meta-analysis of GWAS data with Immunochip 6 validation genotypes from an independent, newly genotyped set of 14,763 Crohn's disease cases, 10,920 ulcerative colitis cases and 15,977 controls was performed ( Supplementary Fig. 1 and Supplementary Table 1 ). Principal-components analysis resolved geographic stratification, as well as Jewish and non-Jewish ancestry ( Supplementary Fig. 4 ), and reduced inflation to a level consistent with residual polygenic risk, rather than other confounding effects (from a median test statistic inflation (l GC ) 5 2.00 to l GC 5 1.23 when analysing all IBD samples; Supplementary Fig. 5 and Supplementary Methods 1b).
Our meta-analysis of the GWAS and Immunochip data identified 193 statistically independent signals of association at genomewide significance (P , 5 3 10 28 ) in at least one of the three analyses (Crohn's disease, ulcerative colitis, IBD). Because some of these signals ( Supplementary Fig. 6 ) probably represent associations to the same underlying functional unit, we merged these signals (Supplementary Methods 1b) into 163 regions, 71 of which are reported here for the first time (Table 1 and Supplementary Table 2 ). Fig. 1a shows the relative contributions of each locus to the total variance explained in ulcerative colitis and Crohn's disease. We have increased the total disease variance explained (variance being subject to fewer assumptions than heritability 7 ) from 8.2% to 13.6% in Crohn's disease and from 4.1% to 7.5% in ulcerative colitis (Supplementary Methods 1c). Consistent with previous studies, our IBD risk loci seem to act independently, with no significant evidence of deviation from an additive combination of log odds ratios.
Our combined genome-wide analysis of Crohn's disease and ulcerative colitis enables a more comprehensive analysis of disease specificity than was previously possible. A model-selection analysis (Supplementary Methods 1c) showed that 110 out of 163 loci are associated with both disease phenotypes; 50 of these have an indistinguishable effect size in ulcerative colitis and Crohn's disease, whereas 60 show evidence of heterogeneous effects (Table 1) . Of the remaining loci, 30 are classified as Crohn's-disease-specific and 23 as ulcerative-colitis-specific. However, 43 of these 53 loci show the same direction of effect in the non-associated disease ( Fig. 1b ; overall P 5 2.8 3 10 26 ). Risk alleles at two Crohn's disease loci, PTPN22 and NOD2, show significant (P , 0.005) protective effects in ulcerative colitis, exceptions that may reflect biological differences between the two diseases. This degree of sharing of genetic risk suggests that nearly all of the biological mechanisms involved in one disease have some role in the other.
The large number of IBD associations, far more than reported for any other complex disease, increases the power of network-based analyses to prioritize genes within loci. We investigated the IBD loci using functional annotation and empirical gene network tools (Supplementary Table 2 ). Compared with previous analyses that identified candidate genes in 35% of loci 2,3 our updated GRAIL 8 -connectivity network identifies candidates in 53% of loci, including increased statistical significance for 58 of the 73 candidates from previous analyses. The new candidates come not only from genes within newly identified loci, but also integrate additional genes from previously established loci ( Fig. 1c ). Only 29 IBD-associated SNPs are in strong linkage disequilibrium (r 2 . 0.8) with a missense variant in the 1000 Genomes Project data, which reinforces previous evidence that a large fraction of risk for complex disease is driven by non-coding variation. By contrast, 64 IBD-associated SNPs are in linkage disequilibrium with variants known to regulate gene expression (Supplementary Table 2 ). Overall, we highlighted a total of 300 candidate genes in 125 loci, of which 39 contained a single gene supported by two or more methods.
Seventy per cent (113 out of 163) of the IBD loci are shared with other complex diseases or traits, including 66 among the 154 loci previously associated with other immune-mediated diseases 9 , which is 8.6-times the number that would be expected by chance (P , 10 216 ; Fig. 2a and Supplementary Fig. 7 ). Such enrichment cannot be attributed to the immune-mediated focus of the Immunochip (Supplementary Methods 4 and Supplementary Fig. 8 ), as the analysis is based on our combined GWAS-Immunochip data. Comparing overlaps with specific diseases is confounded by the variable power in studies of different diseases. For instance, although type 1 diabetes shares the largest number of loci (20 out of 39; tenfold enrichment) with IBD, this is partially driven by the large number of known type 1 diabetes associations. Indeed, seven other immune-mediated diseases 
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show stronger enrichment of overlap, with the largest being ankylosing spondylitis (8 out of 11; 13-fold) and psoriasis (14 out of 17; 14-fold). IBD loci are also markedly enriched (4.9-fold; P , 10 24 ) in genes involved in primary immunodeficiencies (PIDs; Fig. 2a ), which are characterized by a dysfunctional immune system resulting in severe infections 10 . Genes implicated in this overlap correlate with reduced levels of circulating T cells (ADA, CD40, TAP1, TAP2, NBN, BLM, DNMT3B) or of specific subsets, such as T-helper cells producing IL-17 (T H 17 cells) (STAT3), memory (SP110) or regulatory T cells (STAT5B). The subset of PID genes leading to Mendelian susceptibility to mycobacterial disease (MSMD) 10-12 is enriched still further; six of the eight known autosomal genes linked to MSMD are located within IBD loci (IL12B, IFNGR2, STAT1, IRF8, TYK2, STAT3; 46-fold enrichment; P 5 1.3 3 10 26 ), and a seventh, IFNGR1, narrowly missed genome-wide significance (P 5 6 3 10 28 ). Overlap with IBD is also seen in complex mycobacterial disease; we find IBD associations in seven out of eight loci identified by leprosy GWAS 13 , including six cases in which the same SNP is implicated. Furthermore, genetic defects in STAT3 (refs 14, 15) and CARD9 (ref. 16 ), also within IBD loci, lead to PIDs involving skin infections with Staphylococcus and candidiasis, respectively. The comparative effects of IBD and infectiousdisease-susceptibility-risk alleles on gene function and expression are summarized in Supplementary Table 3 , and include both opposite (for example, NOD2 and STAT3; Supplementary Fig. 9 ) and similar (for example, IFNGR2) directional effects.
To extend our understanding of the fundamental biology of IBD pathogenesis we conducted searches across the IBD locus list: (1) for enrichment of specific Gene Ontology terms and canonical pathways;
(2) for evidence of selective pressure acting on specific variants and pathways; and (3) for enrichment of differentially expressed genes across immune-cell types. We tested the 300 prioritized genes (see above) for enrichment in Gene Ontology terms (Supplementary Methods 4a) and identified 286 Gene Ontology terms and 56 pathways demonstrating significant enrichment in genes contained within IBD loci ( Supplementary Figs 10 and 11 and Supplementary Table 4 ). Excluding high-level Gene Ontology categories such as 'immune system processes' (P 5 3.5 3 10 226 ), the most significantly enriched term is regulation of cytokine production (P 5 2.7 3 10 224 ), specifically 
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interferon-c, interleukin (IL)-12, tumour-necrosis factor-a and IL-10 signalling. Lymphocyte activation was the next most significant (P 5 1.8 3 10 223 ), with activation of T cells, B cells and natural killer (NK) cells being the strongest contributors to this signal. Strong enrichment was also seen for response to molecules of bacterial origin (P 5 2.4 3 10 220 ), and for the Kyoto Encyclopedia of Genes and Genomes (KEGG) JAK-STAT signalling pathway (P 5 4.8 3 10 215 ). We note that no enriched terms or pathways showed specific evidence of Crohn's disease or ulcerative colitis specificity. As infectious organisms are known to be among the strongest agents of natural selection, we investigated whether the IBD-associated variants are subject to selective pressures (Supplementary Table 5 and Supplementary Methods 4c). Directional selection would imply that the balance between these forces shifted in one direction over the course of human history, whereas balancing selection would suggest an allele-frequency-dependent scenario typified by host-microbe co-evolution, as can be observed with parasites. Two SNPs show Bonferroni-significant selection: the most significant signal, in NOD2, is under balancing selection (P 5 5.2 3 10 25 ), and the second most significant, in the receptor TNFRSF18, showed directional selection (P 5 8.9 3 10 25 ). The next most significant variants were in the ligand of that receptor, TNFSF18 (directional; P 5 5.2 3 10 24 ), and IL23R (balancing; P 5 1.5 3 10 23 ). As a group, the IBD variants show significant enrichment in selection (Fig. 2b ) of both types (P 5 5.5 3 10 26 ). We discovered an enrichment of balancing selection (Fig. 2b) in genes annotated with the Gene Ontology term 'regulation of interleukin-17 production' (P 5 1.4 3 10 24 ). The important role of IL-17 in both bacterial defence and autoimmunity suggests a key role for balancing selection in maintaining the genetic relationship between inflammation and infection, and this is reinforced by a nominal enrichment of balancing selection in loci annotated with the broader Gene Ontology term 'defense response to bacterium' (P 5 0.007).
We tested for enrichment of cell-type expression specificity of genes in IBD loci in 223 distinct sets of sorted, mouse-derived immune cells from the Immunological Genome Consortium 17 . Dendritic cells showed the strongest enrichment, followed by weaker signals that support the Gene Ontology analysis, including CD4 1 T cells, NK cells and NKT cells (Fig. 2c) . Notably, several of these cell types express genes near our IBD associations much more specifically when stimulated; our strongest signal, a lung-derived dendritic cell, had P stimulated , 1 3 10 26 compared with P unstimulated 5 0.0015, consistent with an important role for cell activation.
To further our goal of identifying likely causal genes within our susceptibility loci and to elucidate networks underlying IBD pathogenesis, we screened the associated genes against 211 co-expression modules identified from weighted gene co-expression network analyses 18 , conducted with large gene-expression data sets from multiple tissues [19] [20] [21] .
The most significantly enriched module comprised 523 genes from omental adipose tissue collected from morbidly obese patients 19 , which was found to be 2.9-fold enriched for genes in the IBD-associated loci (P 5 1.1 3 10 213 ; Supplementary Fig. 12 and Supplementary Table 6 ). We constructed a probabilistic causal gene network using an integrative Bayesian network-reconstruction algorithm [22] [23] [24] , which combines expression and genotype data to infer the direction of causality between genes with correlated expression. The intersection of this network and the genes in the IBD-enriched module defined a subnetwork of genes enriched in bone marrow-derived macrophages (P , 10 216 ) and is suggestive of dynamic interactions relevant to IBD pathogenesis. In particular, this sub-network featured close proximity among genes connected to host interaction with bacteria, notably NOD2, IL10 and CARD9.
A NOD2-focused inspection of the sub-network prioritizes multiple additional candidate genes within IBD-associated regions. For example, a cluster near NOD2 (Fig. 2d ) contains multiple IBD genes implicated in the Mycobacterium tuberculosis response, including SLC11A1, VDR and LGALS9. Furthermore, both SLC11A1 (also known as NRAMP1) and VDR have been associated with M. tuberculosis infection by candidate gene studies 25, 26 , and LGALS9 modulates mycobacteriosis 27 . Of interest, HCK (located in our new locus on chromosome 20 at 30.75 megabases) is predicted to upregulate expression of both NOD2 and IL10, an anti-inflammatory cytokine associated with Mendelian 28 and non-Mendelian 29 IBD. HCK has been linked to alternative, anti-inflammatory activation of monocytes (M2-group macrophages) 30 ; although not identified in our aforementioned analyses, these data implicate HCK as the causal gene in this new IBD locus.
We report one of the largest genetic experiments involving a complex disease undertaken to date. This has increased the number of confirmed IBD susceptibility loci to 163, most of which are associated with both Crohn's disease and ulcerative colitis, and is substantially
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Immune tissue type Enrichment P value RESEARCH LETTER more than reported for any other complex disease. Even this large number of loci explains only a minority of the variance in disease risk, which suggests that other factors-such as rarer genetic variation not captured by GWAS or environmental exposures-make substantial contributions to pathogenesis. Most of the evidence relating to possible causal genes points to an essential role for host defence against infection in IBD. In this regard, the current results focus ever-closer attention on the interaction between the host mucosal immune system and microbes, both at the epithelial cell surface and within the gut lumen.
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In particular, they raise the question, in the context of this burden of IBD-susceptibility genes, of what triggers components of the commensal microbiota to switch from a symbiotic to a pathogenic relationship with the host. Collectively, our findings begin to shed light on these questions and provide a rich source of clues to the pathogenic mechanisms underlying this archetypal complex disease.
METHODS SUMMARY
We conducted a meta-analysis of GWAS data sets after imputation to the HapMap3 reference set, and aimed to replicate in the Immunochip data any SNPs with P , 0.01. We compared likelihoods of different disease models to assess whether each locus was associated with Crohn's disease, ulcerative colitis, or both. We used databases of expression quantitative trait loci SNPs and coding SNPs in linkage disequilibrium with our hit SNPs, as well as the network tools GRAIL and DAPPLE, and a co-expression network analysis to prioritize candidate genes in our loci. Gene Ontology, the Immunological Genome Project (ImmGen) mouse immune-cell-expression resource, the TreeMix selection software and a Bayesian causal network analysis were used to functionally annotate these genes.
